Is it Possible to Safely Maintain a Regular Vascular Practice During the COVID-19 Pandemic?


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
07 2020
Historique:
received: 19 04 2020
revised: 06 05 2020
accepted: 13 05 2020
pubmed: 6 6 2020
medline: 14 7 2020
entrez: 6 6 2020
Statut: ppublish

Résumé

This study aimed to evaluate the protocol adopted during the emergency phase of the COVID-19 pandemic to maintain elective activity in a vascular surgery unit while minimising the risk of contamination to both patients and physicians, and the impact of this activity on the intensive care (IC) resources. The activity of a vascular surgery unit was analysed from 8 March to 8 April 2020. Surgical activity was maintained only for acute or elective procedures obeying priority criteria. The preventive screening protocol consisted of nasopharyngeal swabs (NPS) for all patients and physicians with symptoms and for unprotected contact infected cases, and serological physician evaluations every 15 days. Patients treated in the acute setting were considered theoretically infected and the necessary protective devices were used. The number of patients and the possible infection of physicians were evaluated. The number and type of interventions and the need for post-operative IC during this period were compared with those in the same periods in 2018 and 2019. One hundred and fifty-one interventions were performed, of which 34 (23%) were acute/emergency. The total number of interventions was similar to those performed in the same periods in 2019 and 2018: 150 (33, of which 22% acute/emergency) and 117 (29, 25% acute/emergency), respectively. IC was necessary after 6% (17% in 2019 and 20% in 2018) of elective operations and 33% (11) of acute/emergency interventions. None of the patients treated electively were diagnosed with COVID-19 infection during hospitalisation. Of the 34 patients treated in acute/emergency interventions, five (15%) were diagnosed with COVID-19 infection. It was necessary to screen 14 (47%) vascular surgeons with NPS after contact with infected colleagues, but none for unprotected contact with patients; all were found to be negative on NPS and serological evaluation. A dedicated protocol allowed maintenance of regular elective vascular surgery activity during the emergency phase of the COVID-19 pandemic, with no contamination of patients or physicians and minimal need for IC resources.

Identifiants

pubmed: 32499169
pii: S1078-5884(20)30446-9
doi: 10.1016/j.ejvs.2020.05.024
pmc: PMC7236703
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-134

Informations de copyright

Copyright © 2020 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Références

J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32102856
J Vasc Surg. 2020 Jul;72(1):8-11
pubmed: 32305384
Eur J Vasc Endovasc Surg. 2020 May;59(5):695-696
pubmed: 32303451
N Engl J Med. 1991 Aug 15;325(7):445-53
pubmed: 1852179
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32277022

Auteurs

Rodolfo Pini (R)

Vascular Surgery Metropolitan Unit, University of Bologna, DIMES, Policlinico S. Orsola and Ospedale Maggiore, Bologna, Italy.

Gianluca Faggioli (G)

Vascular Surgery Metropolitan Unit, University of Bologna, DIMES, Policlinico S. Orsola and Ospedale Maggiore, Bologna, Italy. Electronic address: gianluca.faggioli@unibo.it.

Andrea Vacirca (A)

Vascular Surgery Metropolitan Unit, University of Bologna, DIMES, Policlinico S. Orsola and Ospedale Maggiore, Bologna, Italy.

Enrico Gallitto (E)

Vascular Surgery Metropolitan Unit, University of Bologna, DIMES, Policlinico S. Orsola and Ospedale Maggiore, Bologna, Italy.

Chiara Mascoli (C)

Vascular Surgery Metropolitan Unit, University of Bologna, DIMES, Policlinico S. Orsola and Ospedale Maggiore, Bologna, Italy.

Luciano Attard (L)

Infective Disease Unit, University of Bologna, DIMEC, Policlinico S.Orsola, Bologna, Italy.

Pierluigi Viale (P)

Infective Disease Unit, University of Bologna, DIMEC, Policlinico S.Orsola, Bologna, Italy.

Mauro Gargiulo (M)

Vascular Surgery Metropolitan Unit, University of Bologna, DIMES, Policlinico S. Orsola and Ospedale Maggiore, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH